Literature DB >> 31508222

Mechanisms of Action of Drugs Effective in Hepatocellular Carcinoma.

Samantha Sarcognato1,2, Teresa García-Lezana1, Augusto Villanueva1,3.   

Abstract

Entities:  

Year:  2019        PMID： 31508222      PMCID： PMC6726381          DOI： 10.1002/cld.810

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  10 in total

Review 1.  Molecular therapies and precision medicine for hepatocellular carcinoma.

Authors:  Josep M Llovet; Robert Montal; Daniela Sia; Richard S Finn
Journal:  Nat Rev Clin Oncol       Date:  2018-10       Impact factor: 66.675

Review 2.  EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.

Authors: 
Journal:  J Hepatol       Date:  2018-04-05       Impact factor: 25.083

3.  Proliferation Markers Are Associated with MET Expression in Hepatocellular Carcinoma and Predict Tivantinib Sensitivity In Vitro.

Authors:  Sandra Rebouissou; Tiziana La Bella; Samia Rekik; Sandrine Imbeaud; Anna-Line Calatayud; Nataliya Rohr-Udilova; Yoann Martin; Gabrielle Couchy; Paulette Bioulac-Sage; Bettina Grasl-Kraupp; Leanne de Koning; Nathalie Ganne-Carrié; Jean-Charles Nault; Marianne Ziol; Jessica Zucman-Rossi
Journal:  Clin Cancer Res       Date:  2017-02-28       Impact factor: 12.531

Review 4.  Hepatocellular carcinoma.

Authors:  Josep M Llovet; Jessica Zucman-Rossi; Eli Pikarsky; Bruno Sangro; Myron Schwartz; Morris Sherman; Gregory Gores
Journal:  Nat Rev Dis Primers       Date:  2016-04-14       Impact factor: 52.329

Review 5.  Immunotherapy of Hepatocellular Carcinoma: Facts and Hopes.

Authors:  Mercedes Iñarrairaegui; Ignacio Melero; Bruno Sangro
Journal:  Clin Cancer Res       Date:  2017-11-14       Impact factor: 12.531

Review 6.  Advances in targeted therapies for hepatocellular carcinoma in the genomic era.

Authors:  Josep M Llovet; Augusto Villanueva; Anja Lachenmayer; Richard S Finn
Journal:  Nat Rev Clin Oncol       Date:  2015-06-09       Impact factor: 66.675

Review 7.  Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.

Authors:  Jessica Zucman-Rossi; Augusto Villanueva; Jean-Charles Nault; Josep M Llovet
Journal:  Gastroenterology       Date:  2015-06-20       Impact factor: 22.682

Review 8.  Hepatocellular carcinoma: reasons for phase III failure and novel perspectives on trial design.

Authors:  Josep M Llovet; Virginia Hernandez-Gea
Journal:  Clin Cancer Res       Date:  2014-03-03       Impact factor: 12.531

Review 9.  VEGF signaling in cancer treatment.

Authors:  Daniela Sia; Clara Alsinet; Pippa Newell; Augusto Villanueva
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 10.  Checkpoint blockade-based immunotherapy in the context of tumor microenvironment: Opportunities and challenges.

Authors:  Jingjing Duan; Yu Wang; Shunchang Jiao
Journal:  Cancer Med       Date:  2018-08-07       Impact factor: 4.452
  10 in total
  3 in total

1.  TUG1 long non-coding RNA enlists the USF1 transcription factor to overexpress ROMO1 leading to hepatocellular carcinoma growth and metastasis.

Authors:  Shihai Liu; Jing Qiu; Weitai He; Chao Geng; Guifang He; Changchang Liu; Duo Cai; Xiangping Liu; Ben Tian; Huazheng Pan
Journal:  MedComm (2020)       Date:  2020-11-26

2.  Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma progressing after molecular targeted therapy: A multicenter prospective observational study.

Authors:  Rie Sugimoto; Takeaki Satoh; Akihiro Ueda; Takeshi Senju; Yuki Tanaka; Shinsaku Yamashita; Toshimasa Koyanagi; Tomoyuki Kurashige; Nobito Higuchi; Tsukasa Nakamura; Masatake Tanaka; Yuuki Azuma; Akari Ohno; Aritsune Ooho; Mari Ooe; Taiji Mutsuki; Koutarou Uchimura; Masami Kuniyoshi; Seiya Tada; Yoshifusa Aratake; Tsuyoshi Yoshimoto; Naoki Yamashita; Shigeru Harada; Makoto Nakamuta; Kenta Motomura; Motoyuki Kohjima
Journal:  Medicine (Baltimore)       Date:  2022-10-07       Impact factor: 1.817

3.  Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinoma.

Authors:  I G Rapposelli; S Shimose; T Kumada; S Okamura; A Hiraoka; G G Di Costanzo; F Marra; E Tamburini; A Forgione; F G Foschi; M Silletta; S Lonardi; G Masi; M Scartozzi; M Nakano; H Shibata; K Kawata; A Pellino; C Vivaldi; E Lai; A Takata; K Tajiri; H Toyoda; R Tortora; C Campani; M G Viola; F Piscaglia; F Conti; C A M Fulgenzi; G L Frassineti; M D Rizzato; F Salani; G Astara; T Torimura; M Atsukawa; T Tada; V Burgio; M Rimini; S Cascinu; A Casadei-Gardini
Journal:  ESMO Open       Date:  2021-06-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.